Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.

Atherosclerosis - 1 Nov 2009

Fadini Gian Paolo, de Kreutzenberg Saula, Agostini Carlo, Boscaro Elisa, Tiengo Antonio, Dimmeler Stefanie, Avogaro Angelo

Abstract excerpt

OBJECTIVES: Metabolic syndrome (MetS) associates with endothelial dysfunction and a high risk of cardiovascular events and death. Circulating progenitor cells have been shown to contribute to endothelial homeostasis and repair . We aimed to test whether progenitor cell count is an independent event predictor and modifies cardiovascular risk associated with MetS. METHODS: On the basis of the expression of CD34,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Antigens, CD34

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Count

Share to Glycoproteins

Share to Metabolic Syndrome

Share to Proportional Hazards Models

Share to ROC Curve

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 19406403
DOI: 10.1016/j.atherosclerosis.2009.03.040

Genes

KDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.PMID 19406403Read ↗

Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.Semantic proximity Read ↗

Circulating CD34+ progenitor cell frequency is associated with clinical and genetic factorsSemantic proximity Read ↗

Endothelial progenitor cells: diagnostic and therapeutic considerationsSemantic proximity Read ↗

Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.Semantic proximity Read ↗

Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.Semantic proximity Read ↗

Endothelial Progenitor Cells and Cardiovascular CorrelatesSemantic proximity Read ↗

Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.Semantic proximity Read ↗

Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and DiseaseSemantic proximity Read ↗

New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration.Semantic proximity Read ↗

Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.Semantic proximity Read ↗

Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.Semantic proximity Read ↗

Endothelial progenitor cells in vascular health: focus on lifestyle.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.